Timbie Thomas E's Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Aug 5, 2022
- Accession no.
- 0001209191-22-044621
- Filed
- Aug 5, 2022
- Trade date
- Aug 3-5, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.81M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Timbie Thomas ECIK 0001188309 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | SSaleDisposed | −96,879 | $18.85 | −$1,826,169.15 | 1,552,190 | Indirect | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −48,217 | $18.56 | −$894,907.52 | 1,503,973 | Indirect | |
| Aug 5, 2022 | Common Stock | SSaleDisposed | −4,904 | $19.04 | −$93,372.16 | 1,499,069 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.